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ABSTRACT
Background The inflamed bronchial mucosal surface is
a profoundly hypoxic environment. Neutrophilic airway
inflammation and neutrophil-derived proteases have
been linked to disease progression in conditions such as
COPD and cystic fibrosis, but the effects of hypoxia on
potentially harmful neutrophil functional responses such
as degranulation are unknown.
Methods and results Following exposure to hypoxia
(0.8% oxygen, 3 kPa for 4 h), neutrophils stimulated
with inflammatory agonists (granulocyte-macrophage
colony stimulating factor or platelet-activating factor and
formylated peptide) displayed a markedly augmented
(twofold to sixfold) release of azurophilic (neutrophil
elastase, myeloperoxidase), specific (lactoferrin) and
gelatinase (matrix metalloproteinase-9) granule contents.
Neutrophil supernatants derived under hypoxic but not
normoxic conditions induced extensive airway epithelial
cell detachment and death, which was prevented by
coincubation with the antiprotease α-1 antitrypsin; both
normoxic and hypoxic supernatants impaired ciliary
function. Surprisingly, the hypoxic upregulation of
neutrophil degranulation was not dependent on hypoxia-
inducible factor (HIF), nor was it fully reversed by
inhibition of phospholipase C signalling. Hypoxia
augmented the resting and cytokine-stimulated
phosphorylation of AKT, and inhibition of
phosphoinositide 3-kinase (PI3K)γ (but not other PI3K
isoforms) prevented the hypoxic upregulation of
neutrophil elastase release.
Conclusion Hypoxia augments neutrophil
degranulation and confers enhanced potential for
damage to respiratory airway epithelial cells in a
HIF-independent but PI3Kγ-dependent fashion.
INTRODUCTION
The neutrophil is the principal cellular effector of
innate immune responses and the host’s front-line
defence against pathogens at mucosal surfaces.
Severe neutropenia or defects of neutrophil func-
tion confer enhanced susceptibility to infection,
and such episodes may be life-threatening. The
‘flip’ side of the neutrophils’ protective role is that
inappropriate or excessive activation is associated
with inflammatory disease, with the powerful neu-
trophil armamentarium being deployed against
delicate host tissues. There is compelling evidence
from humans and from experimental animal
models that neutrophil influx incites pathological
inflammation in multiple organs1 and contributes
to the pathogenesis of conditions such as acute
lung injury,2 inflammatory bowel disease3 and
rheumatoid arthritis.4 The propensity of neutro-
phils to injure surrounding tissues is intimately
related to their activation status, with priming for
enhanced degranulation and respiratory burst activ-
ity a prerequisite for significant damage.5
Even in health, neutrophils are exposed to major
changes in oxygen availability as they transit
between the arterial and venous circulations. In
normal tissues, cells located away from capillaries
beyond the oxygen diffusion limit (80–140 μm)6
are exposed to low oxygen tensions, and hence
exist in a state of ‘physiological hypoxia’. Injurious
processes such as inflammation and infection
amplify physiological hypoxia and comprise ‘patho-
logical hypoxia’. For example, despite direct expos-
ure to atmospheric oxygen, the keratinocyte layer
of the skin is a naturally hypoxic milieu7; in associ-
ation with neutrophilic infiltration, the microenvir-
onment of the skin becomes profoundly hypoxic.8
Infiltrating neutrophils may contribute directly to
oxygen depletion at inflamed surfaces by means of
Key messages
What is the key question?
▸ Does hypoxia promote neutrophil degranulation
and promote tissue injury?
What is the bottom line?
▸ Levels of hypoxia relevant to airway
inflammation in vivo markedly increase the
release of all neutrophil granule subtypes,
augmenting the capacity for
neutrophil-mediated bronchial epithelial
damage in a phosphoinositide 3-kinase
(PI3K)-dependent manner.
Why read on?
▸ We present evidence that tissue hypoxia
augments neutrophil-mediated injury, a process
that is relevant to airway and lung
parenchymal inflammation/infection and
amenable to PI3Kγ inhibition.
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intense use of oxygen by the nicotinamide adenine dinucleotide
phophate-oxidase (NADPH oxidase), elegantly demonstrated in
the colonic mucosa.9
Like the skin, the airway is ‘bathed’ in ambient oxygen, yet
increased expression of hypoxia-inducible factor (HIF)-1α has
been detected in the bronchial epithelium in COPD.10 More
compellingly (since inflammatory mediators also upregulate the
expression of HIF),11 the airway epithelium of mice overexpres-
sing the β-epithelial Na+ channel (a model of cystic fibrosis
(CF)) stained strongly with the specific hypoxia probe pimonida-
zole hydrochloride (Hypoxyprobe,12 which binds at a threshold
of ≤1.3 kPa O213), confirming that the inflamed airway is a pro-
foundly hypoxic environment. Neutrophils infiltrate the
hypoxic bronchial tissues in patients with COPD,14 and airway
neutrophilia correlates with decline in lung function15 and with
HRCT indicators of peripheral airway dysfunction.16 Likewise,
neutrophilic airway inflammation correlates with disease pro-
gression in CF,17 and has been linked to hypoxic airway epithe-
lial necrosis.18 Finally, respiratory infection is associated with
profound local hypoxia, demonstrated directly in animal models
by the local uptake of Hypoxyprobe.19 Therefore, neutrophils
recruited to inflammatory or infective environments at airway
mucosal surfaces or within the lung parenchymal tissue are
required to function under conditions of significant hypoxia.
Neutrophils are adapted to function in hypoxic environments,
and even under conditions of high oxygen tension, they rely
predominantly on glycolysis for ATP generation.20 While the
effector functions of these cells have been studied extensively
under conditions of ambient oxygen, the few studies that have
examined the ability of these cells to operate under conditions
of hypoxia have demonstrated profound effects on both func-
tion and longevity. We have previously shown that hypoxia
enhances neutrophil survival by inhibition of apoptosis via
HIF-1α-mediated nuclear factor (NF)-κβ activation.21 More
recent data from our laboratory has shown that while neutrophil
chemotaxis and phagocytosis are preserved under conditions of
profound hypoxia, the ability to mount an oxidative burst and
consequent killing of organisms such as Staphylococcus aureus
are markedly impaired.22
Since neutrophil-derived proteases play such a key role in the
pathogenesis of COPD23 and CF,24 and local tissue hypoxia is
highly relevant to airway inflammation in these conditions, we
explored the impact of hypoxia on neutrophil degranulation
responses. We found that hypoxia markedly upregulates the
release of all major neutrophil granule populations, to an extent
that promotes damage to respiratory epithelial cells in culture.
This hypoxic potentiation of degranulation and injurious poten-
tial was not mediated by HIF-1α, a pivotal regulator of hypoxic
signalling, but was associated with enhanced basal and
cytokine-stimulated neutrophil AKT phosphorylation. Inhibitor
studies demonstrated a role for phosphoinositide 3-kinase
(PI3K)γ in mediating hypoxia-enhanced degranulation.
METHODS
Isolation and culture of peripheral blood neutrophils
Cambridge Research Ethics Committee granted ethical approval
(06/Q0108/281). Neutrophils were purified from healthy
volunteers by dextran sedimentation and discontinuous
plasma–Percoll gradients.25 Purified (>98% pure) cells were
resuspended at 5–11×106/mL in Iscove’s Modified Dulbecco’s
Medium (IMDM). Hypoxia was established using an InvivO2
400 hypoxic workstation (Ruskinn, Bridgend, UK), with pre-
equilibration of media. Normoxic incubations used IMDM equi-
librated under ambient atmospheric conditions at 37°C. The
pO2, pCO2 and pH of the media were measured (ABL80 Blood
Gas Analyzer; Radiometer, Copenhagen, Denmark) at the
beginning and at the end of each experiment (see refs. 21, 22
and supplementary figure S1A).
Determination of neutrophil degranulation
Neutrophils (3×106 in 270 μL medium) were incubated in IMDM
under normoxia or hypoxia for 4 h. Granulocyte-macrophage
colony stimulating factor (GM-CSF) (10 ng/mL), tumour necrosis
factor-alpha (TNFα) (20 ng/mL), platelet-activating factor (PAF)
(1 μM) or vehicle control were added for 5–30 min as indicated,
followed by the formylated peptide (fMLP) (100 nM) or vehicle
for 10 min. After centrifugation, degranulation was assessed by
measuring elastase, myeloperoxidase (MPO), lactoferrin and
matrix metalloproteinase-9 (MMP-9) in the supernatants. Active
elastase release was measured using a commercial kit (EnzChek,
Life Technologies, UK). MPO secretion was measured by the
H2O2-dependent oxidation of o-Dianisidine dihydrochloride.
26
Lactoferrin (Hycult Biotech, Uden, The Netherlands) and MMP-9
(R&D, UK) release were measured using commercial ELISA’,
according to the manufacturers’ instructions. MMP-9 activity was
quantified by gelatine zymography.27
Neutrophil apoptosis and neutrophil extracellular trap
formation
Neutrophils were cytocentrifuged and stained with
May-Grünwald–Giemsa (Merck); apoptotic neutrophils were
defined by pyknotic nuclei. Fluorescein isothiocyanate
(FITC)-annexin–TOPRO-3 staining (Invitrogen) was undertaken
according to manufacturers’ instructions. For NETosis, neutro-
phils (106/mL) were incubated with SYTOX Green (1:1000),
and after 4 h treated with GM-CSF and formylated peptide
(fMLP). Extracellular DNA was measured by fluorescence
absorbance at 485/535 nm, and NETosis was calculated as per-
centage of total DNA from cells lysed at baseline.
Small molecule inhibitors
The pan-PI3K inhibitor LY294002 (10 mM), PI3Kγ inhibitor
AS605240 (3 mM), PI3Kδ inhibitor IC87114 (3 mM), cyclohexi-
mide (1 m/mL), thapsigargin (100 nM) and phospholipase C
(PLC) inhibitor U-73122 (2 mM) were purchased from Sigma.
Jasplakinolide (500 nM) was purchased from Tocris Bioscience.
U-73122 was added 10 min prior to stimulation (fMLP), jaspla-
kinolide 5 min prior to stimulation and thapsigargin immedi-
ately prior to stimulation. PI3K inhibitors were added to cells
either at the beginning of the normoxic/hypoxic incubation or
10 min before fMLP stimulation. Cycloheximide and ethylene
glycol tetraacetic acid (EGTA) (2 mM) were also present from
the outset of the normoxic/hypoxic incubation.
Preparation of cigarette smoke extract
Cigarette smoke extract (CSE) was made by bubbling smoke
from three research-grade 3R4F cigarettes (Kentucky Tobacco
Research Institute) through 25 mL of IMDM. This solution was
designated as 100% CSE and diluted as indicated.
Epithelial cell culture
A549 cells (American Type Culture Collection (ATCC), passage
2–8) were cultured in F-12K medium with penicillin (100 U/
mL), streptomycin (100 mg/mL), amphotericin B (25 mg/mL)
and 10% fetal calf serum. Immortalised human bronchial epi-
thelial cells28 (iHBECs) were cultured in keratinocyte serum-free
media supplemented with bovine pituitary extract (25 μg/mL),
recombinant epidermal growth factor (rEGF) (0.2 ng/mL),
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puromycin (250 ng/mL) and G418 (25 μg/mL, Fisher Scientific,
Loughborough, UK). Primary normal human bronchial epithe-
lial cells (NHBE) cells (Lonza, UK) were grown to a ciliated
phenotype at air–liquid interface.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
(MTT) assay
Confluent A549 cell layers were exposed to neutrophil superna-
tants or vehicle controls for 72 h at 37°C. Following incubation
with MTT (500 mg/mL, 2 h, 37°C), cells were dissolved in
100 mL isopropanol, and absorbance at 540 nm was recorded.
Immunohistochemistry and electron microscopy of epithelial
cell layers
Confluent A549/iHBEC cell layers were exposed to neutrophil
supernatants for 48 h, fixed with 4% paraformaldehyde, stained
for F-actin with rhodamine phalloidin (Invitrogen; 1:200,
30 min) and mounted in ProLong Gold Antifade Mountant
(Invitrogen, UK), with 4’,6-diamidino-2-phenylindole (DAPI) as
the nuclear stain. Quantification (imageJ) measured the area of
cell detachment, three fields of view per well, three wells per
condition. For electron microscopy, NHBE cells were fixed in
4% glutaraldehyde containing 0.1% (v/v) hydrogen peroxide
and osmium tetroxide (2 h at 4°C), embedded in Spurr’’s resin
and imaged using a Philips CM 100 transmission electron
microscope (TEM).
Measurement of ciliary beat frequency
To determine ciliary beat frequency (CBF), ciliated NHBE cells
were exposed to neutrophil supernatants prior to transfer to a
chamber slide. Beating cilia were recorded using a Motion Pro
X4 digital high-speed video camera (Lake Image Systems,
Henrietta, New York, USA) at 250–500 frames/s using a 40×
objective as previously described.29 A minimum of 512 or 1024
frames were captured, respectively. Video sequences were ana-
lysed at reduced frame rates and CBF calculated using ciliaFA.30
TaqMan real-time PCR and western blotting
RNA was isolated using TRI reagent (Sigma-Aldrich,
Gillingham, UK) followed by RNA purification with DNase
digest (RNeasy micro columns, Qiagen, Manchester, UK).
cDNA was generated from 1 μg total RNA, using a
High-Capacity cDNA Kit (Applied Biosystems, Foster City,
California, USA), and quantitative PCR (qPCR) (iCycler;
Bio-Rad, Milpitas, California, USA) was performed using SYBR
Green Master Mix (Sigma-Aldrich) and commercial primers
(Qiagen). Relative gene expression was determined by correcting
cycle thresholds for target genes against housekeeping genes
(β-actin, tyrosine 3-monooxygenase/tryptophan 5-monooxygen-
ase activation protein zeta (YWHAZ)) using GenNorm (http://
medgen.ugent.be/~jvdesomp/genorm). The ΔCT for the target
gene of interest in control, normoxic-stimulated and hypoxic-
stimulated neutrophils was corrected against the value obtained
in freshly isolated neutrophils to give ΔΔCT values. Fold-change
in gene expression is expressed as 2−ΔΔCT. Western blotting was
performed using rabbit polyclonal anti-MMP-9 (Abcam), rabbit
polyclonal AKT and rabbit monoclonal serine 473-phospho-
AKT (pAKT) (Cell Signalling Technology).
Statistical analysis
Data are reported as mean±SEM from (n) independent experi-
ments. Gaussian data were analysed using analysis of variance
with Holm–Sidak correction for multiple comparisons, or
paired t test where appropriate. Data that could not be assumed
to be from a Gaussian population were analysed using Kruskal–
Wallis with Dunn’s post-test. All analyses were undertaken using
Prism 6.0g software (GraphPad, San Diego, California, USA). A
p value of <0.05 was considered significant, *p<0.05,
**p<0.01, ***p<0.005, ****p<0.001.
Figure 1 Hypoxia augments neutrophil degranulation. (A–E) Hypoxia augments the release of all granule populations. Neutrophils were incubated
under normoxia or hypoxia for 4 h, primed (granulocyte-macrophage colony stimulating factor (GM-CSF); 10 ng/mL, 30 min) or vehicle controlled
and activated (formylated peptide (fMLP); 100 nM, 10 min), and the supernatants were assayed for the presence of granule proteins. Hypoxia
augmented the release of active elastase (A, n=10, each performed in triplicate) as measured by elastase activity assay, active myeloperoxidase
(MPO) (B, n=8, each performed in triplicate) as measured by the H2O2-dependent oxidation of O-dianisidine dihydrochloride, lactoferrin as measured
by ELISA (C, n=6) and active matrix metalloproteinase-9 (MMP-9) as measured by ELISA (D, n=5, each performed in triplicate) and gelatine
zymography (E, n=3, each performed in triplicate plus representative zymogram, inset). (F and G) Neutrophils were incubated under normoxia or
hypoxia for 4 h prior to priming with platelet-activating factor (PAF) (1 mM, 5 min, n=4, each performed in triplicate) or TNFα (G, 20 ng/mL 30 min,
n=10, each performed in triplicate) or media control and activation with fMLP (100 nM, 10 min), and the supernatants were assessed by elastase
activity assay as above. Results represent mean±SEM. **p<0.01, ***p<0.005.
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RESULTS
Hypoxia augments neutrophil degranulation
Neutrophils cultured in ambient air (‘normoxia’) released
minimal active neutrophil elastase (NE) even when stimulated
with physiological agonists (GM-CSF and fMLP in combin-
ation). Hypoxic incubation (3 kPa, 4 h) increased the stimulated
release of active NE up to sixfold (figure 1A). To determine
whether this reflected augmented azurophil granule release or
was specific to NE alone, MPO activity was also assessed, and
an identical pattern of hypoxia-enhanced release was observed
(figure 1B). Hypoxia also increased the detection of extracellu-
lar lactoferrin (specific granules: figure 1C) and active MMP-9
(gelatinase granules: figure 1E), demonstrating that hypoxia aug-
ments the release of all neutrophil granule populations, both
basally and on stimulation with physiological agonists.
Equivalent increases in total NE,22 lactoferrin and MMP9
(figure 1C, D) were detected by ELISA. Hypoxia also upregu-
lated fMLP-stimulated NE secretion from PAF-primed but not
TNFα-primed neutrophils (figure 1F, G), demonstrating that
this effect is agonist-specific and does not equate to priming, as
all three agonists augmented the neutrophil oxidative burst
(data not shown). Neutrophil survival under all conditions was
confirmed by trypan blue exclusion, microscopy and
FITC-annexin staining (see online supplementary figure S1B/C);
hence, the augmented degranulation response did not reflect
loss of membrane integrity or cell death. Furthermore, hypoxia
did not increase neutrophil extracellular trap (NET) release in
response to hypoxia alone or in combination with GMCSF/
fMLP (see online supplementary figure S1D). We saw no signifi-
cant effect of CSE on neutrophil degranulation under normoxic
or hypoxic conditions (see online supplementary figure S2),
although CSE did induce the intracellular generation of oxygen
species (ROS), confirming biological activity; the minor uplift of
NE release seen under normoxia with 50% CSE reflected
reduced neutrophil viability, and both were prevented by
hypoxia (data not shown).
Hypoxia increases the injurious potential of neutrophil
supernatants
Neutrophil-derived proteases and proteins released on degranu-
lation cause lung tissue damage.31 Supernatants from normoxic
and hypoxic neutrophils stimulated with GM-CSF and fMLP
were therefore applied to cultured A549 cells, and monolayer
integrity was assessed. Hypoxic neutrophil supernatants induced
Figure 2 Hypoxia increases neutrophil supernatant-mediated epithelial injury. (A–C) Hypoxia increased the injurious potential of neutrophil
supernatants to A549 cells. Confluent cell monolayers were exposed to diluted (1:2.5) supernatants (from neutrophils incubated under normoxic or
hypoxic conditions for 4 h, without (control) or with GM-CSF (GM) and formylated peptide (fMLP) activation)±α1AT (46 μg/mL) for 48–72 h. At
48 h, cell layers were stained (A, representative images from n=6 experiments, each performed in triplicate) for cleaved caspase 3 (red), F-actin
(green) and nuclei (blue). Survival of the A549 cells at 72 h was measured by MTT assay (B, n=11, each performed in triplicate; ***p<0.005,
****p<0.001). Cell layer detachment was quantified with ImageJ (C, n=3, three fields of view per well, performed in triplicate; *p<0.05, **p<0.01
(paired t test)). (D and E) Hypoxia increased the injurious potential of neutrophil supernatants to immortalised human bronchial epithelial cells28
(iHBECs). Confluent cell layers were exposed to neutrophil supernatants (1:2.5 dilution) for 48 h. At 48 h, cell layers were stained (D, representative
images from n=3, each performed in triplicate) for cleaved caspase 3 (red), F-actin (green) and nuclei (blue). Cell layer detachment was quantified
with ImageJ (E, n=3, each performed in triplicate). Results represent mean±SEM.
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Figure 3 Neutrophil supernatants impair ciliary function. Supernatants from neutrophils incubated under normoxic or hypoxic conditions for 4 h,
without (control) or with GM-CSF (GM) and formylated peptide (fMLP) activation were applied to strips of ciliated primary human bronchial
epithelial cells for 2 h. Ciliary function was assessed by high-speed digital video microscopy allowing ciliary beat frequency (CBF, A) and detailed
ciliary beat pattern (CBP, B) analysis as detailed in the Methods section. Results represent mean±SEM (n=3, three movies per ciliated strip of
epithelial cells).
Figure 4 Hypoxic upregulation of neutrophil degranulation is not hypoxia-inducible factor (HIF)-dependent. (A and B) Hypoxia mimetics do not
recapitulate the hypoxic upregulation of neutrophil degranulation. Neutrophils were incubated under normoxia for 4 h±DMOG (dimethyloxalyl
glycine) (1 mM, A) or desferrioxamine (DFO) (1 mM, B) or were incubated under hypoxia (positive control), prior to priming with GM-CSF (GM)
(10 ng/mL, 30 min) and activation with formylated peptide (fMLP) (100 nM, 10 min). Supernatants were assayed for active elastase. Results represent
mean±SEM (n=5–6, each performed in triplicate). (C–E) Hypoxia does not increase granule protein transcription, translation or total protein.
Neutrophils were incubated under normoxia or hypoxia for 4 h before RNA isolation or protein quantification. (C) Granule protein (NE, neutrophil
elastase and MMP-9, matrix metalloproteinase-9) and BNIP (BCL2/adenovirus E1B 19 kd-interacting protein-2, positive control) gene expression as
measured by quantitative PCR (qPCR); results represent mean±SEM (n=3, each performed in triplicate). (D) Gelatinase granule content measured by
western blot analysis of MMP-9; results represent mean±SEM (n=3). (E) Hypoxic elastase release was not prevented when translation was inhibited
by cycloheximide, present for the entire incubation, prior to stimulation with GM-CSF (GM) and fMLP. Results represent mean±SEM (n=5, each
performed in triplicate). (F) Reoxygenation (15 min) of neutrophils before priming and activation does not significantly reduce degranulation as
measured by the release of active elastase. Results represent mean±SEM (n=5, each performed in triplicate). *p<0.05, **p<0.01, ***p<0.005.
1034 Hoenderdos K, et al. Thorax 2016;71:1030–1038. doi:10.1136/thoraxjnl-2015-207604
Respiratory infection
substantial epithelial cell detachment and death (figure 2A, B).
Coincubation with the endogenous protease inhibitor α-1 anti-
trypsin protected A549 cells from injury (figure 2A, C), suggest-
ing that neutrophil-derived proteases are responsible for this
effect. These experiments were recapitulated using iHBECs, and
again hypoxia augmented the injurious potential of the neutro-
phil supernatants (figure 2D, E), with α-1 antitrypsin conferring
protection (figure 2E, inset). Both normoxic and hypoxic super-
natants compromised CBF and ciliary coordination when applied
to cultured primary NHBE cells (see figure 3A, B and
supplementary videos S1 and S2), suggesting that this function is
exquisitely sensitive to even minimal exposure to neutrophil
granule products, or that an alternative (non-degranulation-
dependent) agent in the supernatant is responsible. Hypoxic
supernatants induced subtle features of cell damage assessed by
electron microscopy at early time points, with a trend to
enhanced lactate dehydrogenase (LDH) release at later times (see
supplementary figure S3).
Hypoxic upregulation of neutrophil degranulation is not
HIF-dependent and does not depend on cytoskeletal
remodelling
The transcription factor HIF-1α mediates most signalling events
initiated by hypoxia; prolongation of neutrophil lifespan under
conditions of hypoxia is mediated by the stabilisation of HIF-1α
and its interaction with the NF-κβ pathway.21 However, two
main lines of evidence suggest that HIF-1α is not the principal
regulator of the hypoxic upregulation of neutrophil
degranulation (figure 4). First, incubation of neutrophils with
the hypoxia mimetics dimethyloxalyl glycine (DMOG) and des-
ferrioxamine, which stabilise HIF, did not recapitulate the
effects of hypoxia on the release of NE (figure 4A, B) or other
granule products (not shown). Second, hypoxic incubation did
not increase the neutrophil content of the relevant granule pro-
teins, either at the message (figure 4C) or protein level (figure
4D); indeed, hypoxia accelerated the time-dependent loss of
MMP-9 protein, perhaps in keeping with the basal secretion
that occurs even in the absence of agonist stimulation on
hypoxic incubation (figure 1D). The enhanced transcription of
the known HIF target BNIP-2 (BCL2/adenovirus E1B 19
kd-interacting protein-2, figure 4C) confirms the engagement of
the HIF pathway under these experimental conditions.
Furthermore, incubation with cycloheximide had no effect on
the degranulation response observed under either normoxic or
hypoxic conditions (figure 4E). In addition, brief reoxygenation
of hypoxic cells (which restores the impaired oxidative and
killing capacity)22 did not affect NE release, suggesting that this
effect is not a consequence of altered ROS-dependent signalling
(figure 4F).
Since the actin cytoskeleton has been implicated in degranula-
tion responses, we explored the role of actin polymerisation
under hypoxia. Hypoxic incubation promotes focal neutrophil
actin polymerisation, leading to the formation of ‘actin caps’
(figure 5A). Cytochalasin B inhibits actin polymerisation and
primes neutrophils for NE release more potently than does
GM-CSF (figure 5B), but jasplakinolide (which promotes actin
Figure 5 Hypoxic upregulation of neutrophil degranulation does not depend on cytoskeletal remodelling. (A) Neutrophils were incubated under
normoxia or hypoxia for 4 h to activation with formylated peptide (fMLP) (100 nM, 5 min). Cells were stained for F-actin (green), neutrophil elastase
(red) and nuclei (blue). Representative images are from n=3 experiments, each performed in triplicate. (B) Neutrophils were incubated under
normoxia or hypoxia for 4 h prior to priming with cytochalasin B (Cyt B: 5 μg/mL, 5 min) and activation with fMLP (100 nM, 10 min); degranulation
was measured by the release of active elastase. Results represent mean±SEM (n=10, each performed in triplicate). (C and D) Induction of actin
polymerisation induces the formation of actin ‘rings’, but does not affect neutrophil degranulation. (C) Neutrophils incubated with jasplakinolide
(1 μM, 5 min) prior to activation with fMLP (100 nM, 10 min). Cells were stained for F-actin (green) and nuclei (blue). (D) Neutrophils were
incubated under normoxia or hypoxia for 4 h prior to priming with GM-CSF (GM) (10 ng/mL, 30 min), treatment with jasplakinolide (1 μM, 5 min)
prior to activation with fMLP (100 nM, 10 min). Degranulation was measured by the release of active elastase. Results represent mean±SEM (n=4,
each performed in triplicate). *p<0.05, ***p<0.005, ****p<0.001.
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polymerisation and induces the formation of subcortical actin
‘rings’, figure 5C) did not diminish the hypoxic upregulation of
NE release (figure 5D). Thus, although hypoxia can modulate
actin polymerisation,32 this mechanism does not underpin the
enhanced degranulation we observed.
PI3K and PLC signalling pathways contribute to the
regulation of neutrophil degranulation
Since the hypoxic augmentation of neutrophil degranulation
was independent of HIF, the so-called ‘master-regulator’ of
hypoxic signalling, we explored the roles of the PI3K and PLC/
Ca2+ signalling pathways, which are also known to contribute
to the degranulation response. Inhibition of the PLC pathway
(figure 6A) and also chelation of extracellular calcium with
EGTA (figure 6B) abolished NE release induced by agonist
stimulation under normoxia, and reduced but did not abolish
degranulation under conditions of hypoxia; thus ‘the hypoxic
uplift’ of this response was still apparent (figure 6B). A non-
significant trend to increased elastase release was seen on treat-
ment with thapsigargin (figure 6C) to augment intracellular
calcium release, again with preservation of the hypoxic effect.
Hypoxia prolonged neutrophil survival, an effect that was
somewhat diminished by pretreatment with LY294002 (figure
7A), suggesting that hypoxia might entrain the PI3K signalling
pathway. Application of a pan-PI3K inhibitor prior to fMLP
stimulation abolished normoxic but not hypoxic degranulation
responses (figure 7B); however, when the inhibitor was added
from the outset of the hypoxic incubation, the hypoxic uplift
was completely abrogated and NE release was effectively
abolished (figure 7C). In keeping with a possible role for PI3K
in mediating the hypoxic upregulation of neutrophil degranula-
tion, AKT phosphorylation in response to GM-CSF was ele-
vated with hypoxic incubation, and occurred in an accelerated
fashion (figure 7D, E). In contrast, AKT phosphorylation fol-
lowing fMLP treatment was not modulated by hypoxia (see
online supplementary figure S4), suggesting that neutrophil
hyper-responsiveness is entrained in response to earlier signal-
ling events. Notably, the hypoxic enhancement of basal and
peak GM–CSF-stimulated AKT phosphorylation was completely
reversed by inhibition of PI3Kγ (figure 7E).
DISCUSSION
Neutrophils are generated within a hypoxic bone marrow niche,
are exposed to intermittent hypoxia in the circulation and are
recruited to the sites of infection and inflammation, which are
almost invariably hypoxic. Despite this, most knowledge of neu-
trophil signalling and function derives from studies conducted
under atmospheric oxygen tensions, not reflecting the in vivo
physiological or pathological setting. We demonstrate that
hypoxic culture (at levels relevant to human disease in vivo)
augments neutrophil degranulation, conferring an enhanced
injurious potential that may be relevant to neutrophilic airway
inflammation in diseases such as COPD and CF, and to inflam-
matory responses in the wider setting.
We show by ELISA that hypoxia increases the liberation of
the cognate proteins from specific (lactoferrin) and gelatinase
(MMP-9) granule populations, consistent with our previous
report of enhanced release of NE from azuophilic granules.22
Figure 6 Phospholipase C (PLC) and calcium signalling regulate neutrophil degranulation but do not mediate the hypoxic uplift. Inhibition of the
PLC pathway (A) or calcium signalling (B) abolished neutrophil elastase release induced by agonist stimulation under normoxia, and reduced but did
not abolish degranulation under conditions of hypoxia. Increasing intracellular calcium (C) induced an increase in degranulation, but similarly did no
abolish the hypoxic uplift induced by hypoxia. Neutrophils were incubated under normoxia or hypoxia for 4 h prior to priming with GM-CSF (GM))
(10 ng/mL, 30 min). Neutrophils were preincubated with a PLC inhibitor (U-73122, 2 μM) for 10 min prior to activation with formylated peptide
(fMLP) (100 nM, 10 min). EGTA (2 mM) was added at the start of the normoxic/hypoxic incubation, and thapsigargin (100 nM) was added
immediately prior to neutrophil activation with fMLP. Cells were spun down and degranulation measured by the release of active elastase. Results
represent mean±SEM (n=4–5, each performed in triplicate). *p<0.05, **p<0.01, ****p<0.001.
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Importantly we demonstrate herein that NE, MPO and MMP-9
are released by hypoxia in a bioactive form, suggesting that con-
comitant release of neutrophil antiproteases such as α-1 anti-
trypsin33 is insufficient to neutralise the liberated protease
activity. However, exogenous α-1 antitrypsin protected airway
epithelial cells from damage induced by hypoxic neutrophil
supernatants, confirming the key role of granule serine pro-
teases in mediating this cellular injury. While endogenous anti-
proteases may be present in inflamed sites, such local defences
fail to protect target cells in the immediate vicinity of a
degranulating neutrophil, in part due to the phenomenon of
quantum proteolysis (protease molecules vastly outnumber the
inhibitor molecules in the immediate pericellular zones)34 and
in part due to the fact that liberated proteases can bind to the
neutrophil cell surface, rendering them resistant to protease
inhibitors by steric hindrance.35 Our experimental findings
suggest that hypoxia will augment these processes to promote
adjacent tissue injury.
Histotoxic proteases such as NE, MPO and MMP-9 are
present in COPD sputum and bronchoalveolar lavage fluid, and
the levels correlate with the indices of disease severity.24
Likewise, in the context of evidence for airway hypoxia in CF,
both NE and MMP-9 are linked to the pathogenesis and progres-
sion of this condition.23 We therefore propose that tissue
hypoxia engenders a detrimental neutrophil phenotype, with
enhanced injurious potential but diminished bactericidal cap-
acity;22 furthermore, hypoxic prolongation of neutrophil lifespan
will increase tissue exposure to these damaging effector cells.
This process may also contribute to the pathogenesis of a range
of other tissue-destructive conditions where hypoxia is relevant,
for example, granulomatous inflammation,36 pleural sepsis and
abscess formation. These scenarios underscore the need to study
neutrophils under conditions of hypoxia and to determine the
mechanism(s) that lead to this aberrant functional phenotype.
HIFs are the key regulators implementing hypoxic cellular
responses, but although we identified putative hypoxia response
elements (HREs) in the promoter sites of MMP-9 and NE, there
was no increase in their mRNA transcript or protein levels in
hypoxic neutrophils. Together with the failure of hypoxia
mimetics to recapitulate, and of cycloheximide to suppress
hypoxia-augmented degranulation, these data suggest a
HIF-independent mechanism. Since calcium flux in neuronal
cells has been reported to be increased by hypoxia,37 we investi-
gated the impact of modulating intracellular calcium levels on
degranulation under normoxic and hypoxic incubation.
Thapsigargin increased NE release, compatible with the pre-
sumption that neutrophil degranulation is a calcium-dependent
function. Although EGTA reduced degranulation, a substantial
release of NE was still detected under hypoxic conditions. This
is consistent with a recent report that STIM1-deficient murine
neutrophils show loss of store-operated calcium entry but only a
minor defect in fMLP-induced degranulation (although lactofer-
rin alone was assayed in this study).38 The release of calcium
from intracellular stores will be preserved in the presence of
EGTA, and it is possible that this is sufficient to initiate some
degranulation responses.
PI3Kγ is a key mediator of neutrophil degranulation, and has
been reported to be upregulated by hypoxia,39 as has activation of
the effector kinase AKT.40 We found that treatment with the
pan-PI3K inhibitor LY294002 abolished the hypoxic uplift of neu-
trophil degranulation, an effect that could be fully recapitulated by
the isoform-selective PI3Kγ inhibitor AS605240 but not by
IC87114 (a compound with relative selectivity for PI3Kδ). In
keeping with a role for the PI3K pathway, hypoxia upregulated the
phosphorylation of AKT in response to GM-CSF; however there
was no effect on the subsequent response to fMLP, suggesting that
the early increase in PI3K-dependent signalling entrains other (as yet
unknown) cellular responses or pathways. Surprisingly, given that
Figure 7 Phosphoinositide 3-kinase (PI3K) signalling contributes to the hypoxic uplift of neutrophil degranulation. (A) Hypoxia induces neutrophil
survival at 20 h, which is prevented by incubation with the pan-PI3K inhibitor LY294002 (10 μM). Results represent mean±SEM (n=4, each
performed in triplicate). (B and C) Inhibition of the PI3K pathway inhibits degranulation and abrogates the hypoxic response. Neutrophils were
incubated under normoxia or hypoxia for 4 h prior to priming with GM-CSF (GM) (10 ng/mL, 30 min). Cells were treated with a pan-PI3K inhibitor
(LY294002, 10 μM), a PI3Kγ-selective inhibitor (AS605240, 3 μM), a PI3Kδ-selective inhibitor (IC87114, 3 μM), either for 10 min prior to activation
with formylated peptide (fMLP) (B) or from the outset of the normoxic/hypoxic incubation (C). Degranulation was measured by the release of active
elastase. Results represent mean±SEM (n=5). (D and E) Hypoxia increases AKT serine-473 phosphorylation after 15 min of GM-CSF stimulation in a
PI3Kγ-dependent fashion. Neutrophils were incubated under normoxia or hypoxia for 4 h prior to priming with GM-CSF (10 ng/mL, 15 min).
Isoform-selective PI3K inhibitors AS605240 (3 μM, PI3Kγ) and IC87114 (3 μM, PI3Kδ) were added at the start of the incubation. p-AKT was
quantified by western blotting. Results represent mean±SEM (n=4–11). *p<0.05, **p<0.01.
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PI3Kγ is generally coupled to ligation of G-protein, rather than tyro-
sine kinase-linked receptors, inhibition of PI3Kγ abolished the AKT
phosphorylation in GM-CSF-treated neutrophils. How hypoxia
might modulate PI3Kγ activity independent of HIF is currently
unknown and is a focus of ongoing investigation in our laboratory.
In summary, levels of hypoxia encountered by inflammatory
cells in pathophysiological situations increase neutrophil
degranulation, deploying harmful proteins and proteases to the
extracellular milieu and increasing the capacity for tissue injury.
The mechanism by which hypoxia engenders this hyperactivated
state does not relate to the established HIF-dependent signalling
pathways, but may involve PI3Kγ.
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